{
    "title": "Pfizer sees steep 2023 fall in COVID sales, aims to bolster pipeline",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11696449/Pfizer-forecasts-weak-2023-sales-COVID-products.html",
    "date": "2023-01-31",
    "keywords": [
        "vaccine",
        "pfizer",
        "revenue",
        "company",
        "covid19",
        "treatment",
        "year",
        "covid",
        "bhanvi",
        "satija",
        "michael",
        "inc",
        "demand",
        "transition",
        "growth",
        "half",
        "analyst",
        "baum",
        "drugmaker",
        "drug",
        "pipeline",
        "paxlovid",
        "countrys",
        "insurance",
        "china",
        "market",
        "tuesday",
        "drop",
        "investor",
        "work",
        "executive",
        "albert",
        "bourla",
        "mark",
        "time",
        "driven",
        "capital",
        "position",
        "conference",
        "call",
        "rampd",
        "engine",
        "virus",
        "rsv",
        "flu",
        "stock",
        "month",
        "dependence",
        "view",
        "business",
        "research",
        "note",
        "decline",
        "headwind",
        "patent",
        "bigselling",
        "cancer",
        "ibrance",
        "xeljanz",
        "buyout",
        "blood",
        "purchase",
        "migraine",
        "citis",
        "spike",
        "excluding",
        "partner",
        "biontech",
        "expectation",
        "comirnaty",
        "government",
        "price",
        "clarity",
        "healthcare",
        "plan",
        "march",
        "forecast",
        "opportunity",
        "evan",
        "seigerman",
        "reporting",
        "bengaluru",
        "erman",
        "jersey",
        "editing",
        "jonathan",
        "oatis",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}